Innovation @ Penn: The Future of Neuroscience

In parallel with the 2024 JP Morgan Healthcare Conference, PCI welcomed a stellar group of innovators to our Innovation @ Penn program in San Francisco on January 8, 2024.
The event was introduced by Ben Dibling, PhD, Managing Director, PCI, and Jim Bowen, PhD, Executive Director, Corporate Alliances, PCI served as moderator.
This year's panel featured an exciting line-up of experts in the field of brain science and neurobiology, including leading luminaries Brian Litt, MD, Perelman Professor of Neurology at Penn Medicine and Director, Penn Health-Tech, Michael Kahana, PhD, Penn SAS Professor of Psychology at the University of Pennsylvania and Co-Founder & Chairman of the Scientific Advisory Board for Nia Therapeutics, and Anna Wexler, PhD, Assistant Professor of Medical Ethics and Health Policy at the University of Pennsylvania.
The panel offered an in-depth discussion regarding a variety of topics, including memory, neuro-ethics, the relationship between AI and neuroscience, and the latest research in the field.
At the end of the panel, Laurie Actman, Chief Marketing, Communications
and Programs Officer, PCI, and Kathryn Doyle, PhD, Esq., Partner, Saul Ewing, presented closing remarks.